
Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial
Author(s) -
Salahaddin Ubaid,
Tom Ford,
Benjamin Wrigley,
Mark R. Thomas,
Heather Murray,
J D Vickers,
Armesilla,
Jonathan N. Townend,
Saib Khogali,
Shahzad Munir,
Joe Martins,
Rumi Jaumdally,
Elisa McAlindon,
James Cotton
Publication year - 2019
Publication title -
clinical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.531
H-Index - 56
eISSN - 1473-4893
pISSN - 1470-2118
DOI - 10.7861/clinmedicine.19-2-s128
Subject(s) - medicine , ticagrelor , percutaneous coronary intervention , cangrelor , myocardial infarction , p2y12 , clopidogrel , cardiology , conventional pci , acute st segment elevation myocardial infarction , st segment , randomized controlled trial , clinical trial , platelet aggregation inhibitor , aspirin